0001144204-17-013333.txt : 20170405 0001144204-17-013333.hdr.sgml : 20170405 20170307204122 ACCESSION NUMBER: 0001144204-17-013333 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alcentra Capital Corp CENTRAL INDEX KEY: 0001578620 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-922-8240 MAIL ADDRESS: STREET 1: 200 PARK AVENUE STREET 2: 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10166 FORMER COMPANY: FORMER CONFORMED NAME: Alcentra Capital Corp. DATE OF NAME CHANGE: 20130605 CORRESP 1 filename1.htm

 

Alcentra Capital Corporation

200 Park Avenue
7th Floor
New York, New York 10166

(212) 922-8240

 

 

March 7, 2017

 

U.S. Securities and Exchange Commission

Division of Investment Management

100 F Street, N.E.

Washington, DC 20549

Attn: Dominic Minore

 

Re:Alcentra Capital Corporation

Registration Statement on Form N-2 (File No. 333-216207)

 

Dear Mr. Minore:

 

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Alcentra Capital Corporation (the “Company”) respectfully requests acceleration of effectiveness of the above-captioned registration statement (the “Registration Statement”), including all amendments thereto, to 3:30 p.m., Eastern Time, on March 8, 2017 or as soon thereafter as possible.

 

In connection with the submission of the Company’s request for accelerated effectiveness of the above-referenced Registration Statement, the Company hereby acknowledges that:

 

·the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

 

·should the Securities and Exchange Commission (the “Commission”) or the staff thereof (the “Staff”), acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

 

·the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

 

·the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

 

Alcentra Capital Corporation

 

 

By: /s/ Paul J. Echausse                    

Name: Paul J. Echausse
Title: President and Chief Executive Officer